A | 秋来满眼丰收景，又是一年丰收季。 Sputnik spoke with Dr. D. B. Bhaaskara, CEO of the multinational company Roerich Healthcare, about the current state of pharma trade with Russia.,Sputnik: Can you explain the current state of pharma supplies to Russia?,D. B. Bhaaskara: Currently, pharmaceutical shipments of Indian firms to Russia are at the same level even after the sanctions. But, there are many proposals (supplies) that Russians are not getting from the European Union. Russians are looking for these materials (chemicals, excipients, APIs [Active Pharmaceutical Ingredients]) with several Indian manufacturers. They have to develop links with Indian firms. There are many proposals from Russia - these proposals are under consideration from the Indian side.,Sputnik: There were reports of delayed payments from Russia initially after sanctions. As we see, trade has jumped manifold in the energy and fertilizer sectors. Do you think payment issues have been resolved in other sectors as well?,D. B. Bhaaskara: Several Indian companies have signed contracts in yuan, which means they are ready to receive payment in China's yuan. Still, the preferred mode of settlement is in the Indian rupee. As export procedures closed successfully in USD/euro/INR, Russians set aside yuan contracts.,My company is receiving regular payment without any delay in Indian rupees or USD or sometimes in euros.,Sputnik: What about logistical issues, as sanctions hit the shipping sector?,D. B. Bhaaskara: The logistical issues are still there because few airlines — namely Aeroflot, Emirates, Qatar, and Turkish — are available for transportation. Transportation costs are slightly high because of no regular cargo consignments. They vary between $8-12 per kg compared to $5 per kg in a normal situation.,Cargo sea shipment is still in a mess. The only port in Gujarat accepts Russian shipping. Here again, the container price is very, very high. We have to pay anything between $9,000 - 12,000 for a container. When there was no conflict or sanctions, it was $2,500 per container.,We have tried to send our shipments via Iran. So, from Gujarat port, the shipment reaches an Iranian port, and from there, it goes via road or rail to Moscow. But, it is taking a much longer time. In general, it is supposed to arrive in 30-40 days, but on an experimental basis, some companies sent their materials via the Iran route, [and they are] still on their way even after two months.,Shanghai is very crowded and has also been hit by the pandemic, making it unsuitable for us. So, the only problem right now is logistics; there is no payment issue.,Some Russian companies have an account with European banks operating in Russia dealing in oil and gas payments. Those banks are being used to send money anywhere worldwide, even with sanctions.,Sputnik: Western firms intended to withdraw their operations in Russia in response to Moscow's special military operation. Do you see some significant investments from Indian pharma companies in Russia to fill the vacuum created by the west?,D. B. Bhaaskara: There are long-pending proposals from a couple of governors, such as [in] Volgograd and Kazan, inviting India's major pharma companies to set up manufacturing units in their region. But, due to the pandemic, nothing moved ahead.,A delegation will be going to Russia to explore the opportunities in Russia in July. A few Indian companies, such as Sun Pharma and Advance Pharma, have manufacturing units in Russia doing finished formulations.,Hopefully, some new companies are interested in setting up units there now. But, Russia is looking to scale up raw material manufacturing, e.g., API. For this, much homework related to regulation should be done between the two governments, especially under sanctions.,Also, big companies such as Sun Pharma, Aurbindo, and Dr. Reddy, all with significant exposure to the US market, may try to avoid investing in Russia because they are scared of the risk associated with sanctions.,Medium-scale companies can come forward to set up raw material (API) manufacturing in Russia. However, it is unclear whether Indian workers/professionals can go and work in Russia. Setting up a new unit in unknown topography with a different language and culture is a little complicated. A lot of these questions are unanswered.。在抚顺这片充满希望的土地上，处处铺满鎏金画卷。
B | 特色农业产业的秋收工作繁忙有序，人们的脸上洋溢着幸福和喜悦，一派欣欣向荣的丰收景象。 日前，记者在抚顺县后安镇辽宁三友农业生物科技集团有限公司新品种培育大棚里看到，一朵朵银白色的玉木耳、一颗颗鲜嫩肥美的松茸长势良好。据了解，这是该公司珍稀菌菇事业部培育的新品种，大面积推广后会给农民带来可观的收入。 辽宁三友农业生物科技集团有限公司生产部部长刘宇超说：“公司目前生产菌种菌棒2500万镑左右，预计产值在7500万元，今年全年预计生产情况3500万到4000万左右，预计产值可以达到1.2亿。” 自2009年开始，抚顺县就将食用菌产业确定为农业产业“一县一业”主导产业，从2015年——2020年，连续5年制定《抚顺县城郊型特色农业扶持政策》，支持抚顺单片黑木耳产业生产、深加工、销售和品牌建设，促进抚顺单片黑木耳产业发展。 抚顺单片黑木耳产品以其独特的品质和口感，驰名全国，获国家农产品地理标志保护认证，被全国食用菌协会评为“全国食用菌产业化发展示范县”。现阶段，抚顺单片黑木耳产量排名全省第一，产品驰名全国。
C | 近年来，抚顺县农业依托自然资源优势，合理规划特色农产品的种植区域，形成了以辽宁三友农业生物科技集团有限公司为核心的食用菌特色农业产业链，食用菌产业不断壮大，带动广大农民增收致富。目前，食用菌生产总量从2014年的3500万袋提升到现在的5000万袋，增长42.9%；产值从1.7亿元提升到2.6亿元；带动农户从2000户增加到3300户，增长65%。 责任编辑：刘春阳。
Current article:http://gijp.minshixuanhabing.bond/x3eklg4/fg6l0ev.html
Published on:05:43:35
